We are live on
!
Find out more
MS
Maven Securities Portfolio holdings
AUM
$5.2B
1-Year Est. Return
44.01%
This Fund
S&P 500
This Quarter
Est. Return
+28.57%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
-$202M
(-17%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-35.04%
Top 10 Holdings %
Top 10 Hldgs %
17.77%
Holding
972
New
385
Increased
62
Reduced
71
Closed
428
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdaptHealth
AHCO
|
+$14.9M |
| 2 |
CLGX
Corelogic, Inc.
CLGX
|
+$14.2M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$13.5M |
| 4 |
GoodRx Holdings
GDRX
|
+$13.3M |
| 5 |
Sotera Health
SHC
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$32.8M |
| 2 |
Caesars Entertainment
CZR
|
+$22.3M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$20.7M |
| 4 |
TRIT
Triterras, Inc. Class A Ordinary Shares
TRIT
|
+$15.2M |
| 5 |
BHP
BHP
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.37% |
| 2 | Technology | 10.24% |
| 3 | Industrials | 10.18% |
| 4 | Financials | 8.13% |
| 5 | Consumer Discretionary | 5.29% |
Similar funds
AUB
AP
KACA
DDC
MIM
AAI
SDIC
SCM
Maven Securities's Q4 2020 Portfolio in Review
As of Q4 2020, Maven Securities held 972 positions worth $1.01B, down 17% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Maven Securities withdrew a net $355M in Q4 2020, closing 428 positions and reducing 71 holdings. Its most notable exit was Immunomedics Inc, an estimated $32.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, Maven Securities opened a new position in Corelogic, Inc. worth $14.7M.
- Maven Securities's largest Q4 2020 buy was Corelogic, Inc.: 189,483 shares worth $14.7M.
- Maven Securities added most to AdaptHealth in Q4 2020, an estimated $14.9M increase.
- Maven Securities's biggest Q4 2020 reduction was Triterras, Inc. Class A Ordinary Shares, cutting an estimated $15.2M.
- Maven Securities fully exited Immunomedics Inc in Q4 2020, selling an estimated $32.8M.
- Maven Securities's ten largest holdings make up 18% of its $1.01B portfolio in Q4 2020.
- Maven Securities opened 385 new positions and closed 428 in Q4 2020.
- Maven Securities's portfolio value fell 17% quarter-over-quarter to $1.01B.
Based on Maven Securities's 13F filing for Q4 2020, filed 12 Feb 2021.